NVTA Invitae Corp

Price (delayed)

$2.54

Market cap

$582.39M

P/E Ratio

N/A

Dividend/share

N/A

EPS

-$2

Enterprise value

$1.98B

itae Corporation is a leading medical genetics company whose mission is to bring comprehensive genetic information into mainstream medicine to improve healthcare for billions of people. Invitae's goal is to ...

Highlights
The revenue has soared by 51% YoY and by 4.4% from the previous quarter
NVTA's gross profit is up by 29% year-on-year
NVTA's EPS has surged by 50% year-on-year but it is down by 11% since the previous quarter
The net income has increased by 26% YoY but it has decreased by 19% from the previous quarter
NVTA's gross margin is down by 15% year-on-year and by 6% since the previous quarter

Key stats

What are the main financial stats of NVTA
Market
Shares outstanding
229.29M
Market cap
$582.39M
Enterprise value
$1.98B
Valuations
Price to earnings (P/E)
N/A
Price to book (P/B)
0.2
Price to sales (P/S)
1.21
EV/EBIT
N/A
EV/EBITDA
N/A
EV/Sales
4.11
Earnings
Revenue
$480.52M
EBIT
-$460.86M
EBITDA
-$369.86M
Free cash flow
-$686.98M
Per share
EPS
-$2
Free cash flow per share
-$3.01
Book value per share
$12.45
Revenue per share
$2.1
TBVPS
$5.76
Balance sheet
Total assets
$4.77B
Total liabilities
$1.92B
Debt
$1.73B
Equity
$2.84B
Working capital
$862.71M
Liquidity
Debt to equity
0.61
Current ratio
6.14
Quick ratio
5.75
Net debt/EBITDA
-3.77
Margins
EBITDA margin
-77%
Gross margin
22.9%
Net margin
-93.9%
Operating margin
-169.7%
Efficiency
Return on assets
-9.1%
Return on equity
-15.6%
Return on invested capital
-20%
Return on capital employed
-10%
Return on sales
-95.9%
Dividend
Dividend yield
N/A
DPS
N/A
Payout ratio
N/A

NVTA stock price

How has the Invitae stock price performed over time
Intraday
-3.05%
1 week
2.83%
1 month
-36.82%
1 year
-92.55%
YTD
-83.37%
QTD
-68.13%

Financial performance

How have Invitae's revenue and profit performed over time
Revenue
$480.52M
Gross profit
$110.23M
Operating income
-$815.38M
Net income
-$451.37M
Gross margin
22.9%
Net margin
-93.9%
NVTA's net margin has surged by 51% year-on-year but it is down by 14% since the previous quarter
The revenue has soared by 51% YoY and by 4.4% from the previous quarter
NVTA's gross profit is up by 29% year-on-year
The net income has increased by 26% YoY but it has decreased by 19% from the previous quarter

Growth

What is Invitae's growth rate over time

Valuation

What is Invitae stock price valuation
P/E
N/A
P/B
0.2
P/S
1.21
EV/EBIT
N/A
EV/EBITDA
N/A
EV/Sales
4.11
NVTA's EPS has surged by 50% year-on-year but it is down by 11% since the previous quarter
The price to book (P/B) is 95% lower than the 5-year quarterly average of 4.4 and 87% lower than the last 4 quarters average of 1.6
The equity has grown by 20% year-on-year but it has declined by 4.5% since the previous quarter
The stock's P/S is 89% less than its 5-year quarterly average of 11.0 and 88% less than its last 4 quarters average of 10.7
The revenue has soared by 51% YoY and by 4.4% from the previous quarter

Efficiency

How efficient is Invitae business performance
NVTA's ROIC has soared by 77% YoY but it is down by 7% from the previous quarter
Invitae's ROE has soared by 67% YoY but it has decreased by 15% from the previous quarter
The company's return on assets has surged by 66% YoY but it fell by 14% QoQ
NVTA's return on sales has surged by 56% year-on-year but it is down by 21% since the previous quarter

Dividends

What is NVTA's dividend
DPS
N/A
Dividend yield
N/A
Payout ratio
N/A

There are no recent dividends present for NVTA.

Financial health

How did Invitae financials performed over time
Invitae's total assets is 148% higher than its total liabilities
The company's total liabilities rose by 29% YoY
NVTA's quick ratio is down by 26% since the previous quarter but it is up by 15% year-on-year
NVTA's debt is 39% smaller than its equity
NVTA's debt to equity has surged by 165% year-on-year and by 5% since the previous quarter
The equity has grown by 20% year-on-year but it has declined by 4.5% since the previous quarter

All financial data is based on trailing twelve months (TTM) periods - updated quarterly, unless otherwise specified.